MariMed Inc Expects to Report That Earnings & Revenue Doubled in 2021
MariMed Inc (OTCMKTS:MRMD), a seed-to-sale cannabis multistate operator, is one of the best-kept secrets in the legal marijuana sector. But it won’t stay that way for long. The company has found a greater audience for its products, it has been expanding its U.S. footprint, and—so far in 2022—it has announced two strategic acquisitions.
MariMed Inc has reported some of the best revenue, earnings, and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) growth in the cannabis industry.
Read more about MRMD stock here.
The post MariMed Stock: Is Overlooked U.S. Pot Stock Poised for 175% Rally? originally appeared at Profit Confidential.